Citi raised the firm’s price target on Zai Lab (ZLAB) to $69 from $66 and keeps a Buy rating on the shares. The firm updated the company’s model post the Q2 report.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ZLAB:
- Zai Lab Reports Growth and Strategic Progress in Q2 2025
- Zai Lab reports Q2 EPS (4c), consensus (42c)
- Zai Lab’s Promising Phase 3 Trial Results and Future Potential Justify Buy Rating
- Zai Lab’s Promising Growth: Successful Trial and Expanding Pipeline Drive Buy Rating
- Zai Lab price target raised to $75 from $73 at Leerink